B Cell
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| COVID-19 Immune Repertoire Sequencing (NCT04368143) | Institute of Tropical Medicine, Belgium | 2020-04-01 |
| Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia (NCT03759184) | National Cancer Institute (NCI) | 2019-07-11 |
| Obinutuzumab, Venetoclax, and Lenalidomide in Treating Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT02992522) | Beth Christian | 2017-02-21 |
| Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients (NCT01862445) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2013-10-01 |
| A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 7/4 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment (NCT01561911) | Cancer Research UK | 2007-07-01 |
Track B Cell automatically
Every clearance here is in the API, with alerts when new ones post.